Class III β-tubulin in advanced NSCLC of adenocarcinoma subtype predicts superior outcome in a randomized trial

Adam Christian Vilmar, Eric Santoni-Rugiu, Jens Benn Sørensen

    36 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Class III β-tubulin in advanced NSCLC of adenocarcinoma subtype predicts superior outcome in a randomized trial'. Together they form a unique fingerprint.

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science